Appointment of Rediger as new CEO of GSK Korea
Jul 30, 2025
|
CEO Guna Lidger, who took over as CEO effective Aug. 1, has led the healthcare business throughout Latin America for more than 20 years since joining GSK's global talent training program 'Future Leaders Program' in 2004. He has held key positions such as GSK Brazil's Vaccines Business Unit Head, BioTech Business Unit Head, and Global Vaccines Market Lead.
From 2023, as Country President & General Manager, GSK Colombia has successfully launched major products in its vaccine, specialty medicine, and oncology portfolio, and GSK Colombia has been selected as the fastest-growing multinational pharmaceutical company in Colombia'2024.
"We are pleased to join GSK Korea, which has achieved outstanding results so far," said Guna Lidiger, CEO of GSK Korea. "We look forward to leading a new chapter in the growth of GSK in Korea by continuously supplying innovative vaccines and medicines that improve the quality of life of Korean patients and strengthening cooperation for the development of the domestic biopharmaceutical industry."
This article was translated by Naver AI translator.
